{"id":477062,"date":"2020-03-31T19:10:01","date_gmt":"2020-03-31T19:10:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=477062"},"modified":"2020-03-31T19:10:01","modified_gmt":"2020-03-31T19:10:01","slug":"hallux-valgus-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/hallux-valgus-analysis-market-size-epidemiology-leading-companies-and-competitive-analysis-by-delveinsight_477062.html","title":{"rendered":"Hallux Valgus Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis By DelveInsight"},"content":{"rendered":"
\"Hallux<\/a><\/div>\n

(Albany, US) DelveInsight has launched a new report on Hallux Valgus Market Insights, Epidemiology and Market Forecast-2030<\/strong><\/p>\n

DelveInsight’s “Hallux Valgus – Market Insights, Epidemiology, and Market Forecast-2030″<\/span> report delivers an in-depth understanding of the Hallux Valgus , historical and forecasted epidemiology as well as the Hallux Valgus market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/p>\n

The Hallux Valgus market report provides current treatment practices, emerging drugs, Hallux Valgus market share of the individual therapies, current and forecasted Hallux Valgus market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Hallux Valgus treatment practice\/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.<\/p>\n

According to the National Institute of Health (NIH), a bunion, known technically as hallux valgus, is a bony bump on the side of the foot at the base of the big toe. Bunions develop slowly as pressure on the joint at the base of the big toe causes the toe to move out of place, leaning inward toward the second toe. It is a progressive foot deformity in which the first metatarsophalangeal (MTP) joint is affected and is often accompanied by significant functional disability and foot pain. At a late stage, these changes lead to pain and functional deficit: i.e. impaired gait (lateral and posterior weight shift, late heel rise, decreased single-limb balance, and pronation deformity.<\/p>\n

\"\"<\/p>\n

 <\/p>\n

Request for :- free sample page<\/em><\/strong><\/a><\/p>\n

Epidemiology<\/em><\/strong><\/p>\n

The Hallux Valgus epidemiology division provide insights about historical and current Hallux Valgus patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.<\/p>\n

Report Key facts:- <\/strong><\/p>\n

1. According to a study conducted by Nix et al. titled “Prevalence of hallux valgus in the general population: a systematic review and meta-analysis”, pooled prevalence estimates for Hallux Valgus were 23% in adults aged 18-65 years and 35.7% in elderly people aged over 65 years. However, the prevalence increased with age and was higher in females [30%] compared to males [13%].<\/p>\n

2. The National health surveys in the United States have reported a prevalence of 0.9% across all age groups, while another survey in the United Kingdom reported a prevalence of 28.4% in adults. Research conducted in elderly populations has indicated prevalence rates as high as 74%. Individual studies have reported that Hallux Valgus is more common in female and elderly individuals than in males.<\/p>\n

Table of content<\/em><\/strong><\/a><\/p>\n

1. Key Insights<\/strong><\/p>\n

2. Executive Summary of Hallux Valgus<\/strong><\/p>\n

3. Competitive Intelligence Analysis for Hallux Valgus<\/strong><\/p>\n

4. Hallux Valgus : Market Overview at a Glance<\/strong><\/p>\n

4.1. Hallux Valgus Total Market Share (%) Distribution in 2017<\/p>\n

4.2. Hallux Valgus Total Market Share (%) Distribution in 2030<\/p>\n

5. Hallux Valgus : Disease Background and Overview<\/strong><\/p>\n

5.1. Introduction<\/p>\n

5.2. Sign and Symptoms <\/p>\n

5.3. Pathophysiology <\/p>\n

5.4. Risk Factors <\/p>\n

5.5. Diagnosis <\/p>\n

6. Patient Journey<\/strong><\/p>\n

7. Hallux Valgus Epidemiology and Patient Population<\/strong><\/p>\n

7.1. Epidemiology Key Findings<\/p>\n

7.2. Assumptions and Rationale: 7MM<\/p>\n

7.3. Epidemiology Scenario: 7MM<\/p>\n

7.3.1. Hallux Valgus Epidemiology Scenario in the 7MM (2017-2030)<\/p>\n

7.4. United States Epidemiology<\/p>\n

7.4.1. Hallux Valgus Epidemiology Scenario in the United States (2017-2030)<\/p>\n

7.5. EU-5 Country-wise Epidemiology<\/p>\n

7.5.1. Germany Epidemiology<\/p>\n

7.5.1.1. Hallux Valgus Epidemiology Scenario in Germany (2017-2030)<\/p>\n

7.5.2. France Epidemiology<\/p>\n

7.5.2.1. Hallux Valgus Epidemiology Scenario in France (2017-2030)<\/p>\n

7.5.3. Italy Epidemiology<\/p>\n

7.5.3.1. Hallux Valgus Epidemiology Scenario in Italy (2017-2030)<\/p>\n

7.5.4. Spain Epidemiology<\/p>\n

7.5.4.1. Hallux Valgus Epidemiology Scenario in Spain (2017-2030)<\/p>\n

7.5.5. United Kingdom Epidemiology<\/p>\n

7.5.5.1. Hallux Valgus Epidemiology Scenario in the United Kingdom (2017-2030)<\/p>\n

7.5.6. Japan Epidemiology<\/p>\n

7.5.6.1. Hallux Valgus Epidemiology Scenario in Japan (2017-2030)<\/p>\n

8. Treatment Algorithm, Current Treatment, and Medical Practices<\/strong><\/p>\n

8.1. Hallux Valgus Treatment and Management<\/p>\n

8.2. Hallux Valgus Treatment Algorithm <\/p>\n

9. Unmet Needs<\/strong><\/p>\n

10. Key Endpoints of Hallux Valgus Treatment<\/strong><\/p>\n

11. Marketed Products<\/strong><\/p>\n

11.1. List of Marketed Products in the 7MM<\/p>\n

11.2. Drug Name: Company Name<\/p>\n

11.2.1. Product Description<\/p>\n

11.2.2. Regulatory Milestones<\/p>\n

11.2.3. Other Developmental Activities<\/p>\n

11.2.4. Pivotal Clinical Trials<\/p>\n

11.2.5. Summary of Pivotal Clinical Trial<\/p>\n

List to be continued in report<\/p>\n

12. Emerging Therapies<\/strong><\/p>\n

12.1. Key Cross<\/p>\n

12.2. Drug Name: Company Name<\/p>\n

12.2.1. Product Description<\/p>\n

12.2.2. Other Developmental Activities<\/p>\n

12.2.3. Clinical Development<\/p>\n

12.2.4. Safety and Efficacy<\/p>\n

12.2.5. Product Profile<\/p>\n

List to be continued in report<\/p>\n

13. Hallux Valgus : Seven Major Market Analysis<\/strong><\/p>\n

13.1. Key Findings<\/p>\n

13.2. Hallux Valgus Market Size in 7MM<\/p>\n

13.3. Hallux Valgus Market Size by Therapies in the 7MM<\/p>\n

14. Attribute analysis<\/strong><\/p>\n

15. 7MM: Market Outlook<\/strong><\/p>\n

15.1. United States: Market Size<\/p>\n

15.1.1. Hallux Valgus Total Market Size in the United States<\/p>\n

15.1.2. Hallux Valgus Market Size by Therapies in the United States<\/p>\n

15.2. EU-5 countries: Market Size and Outlook<\/p>\n

15.3. Germany Market Size<\/p>\n

15.3.1. Hallux Valgus Total Market Size in Germany<\/p>\n

15.3.2. Hallux Valgus Market Size by Therapies in Germany<\/p>\n

15.4. France Market Size<\/p>\n

15.4.1. Hallux Valgus Total Market Size in France<\/p>\n

15.4.2. Hallux Valgus Market Size by Therapies in France<\/p>\n

15.5. Italy Market Size<\/p>\n

15.5.1. Hallux Valgus Total Market Size in Italy<\/p>\n

15.5.2. Hallux Valgus Market Size by Therapies in Italy<\/p>\n

15.6. Spain Market Size<\/p>\n

15.6.1. Hallux Valgus Total Market Size in Spain<\/p>\n

15.6.2. Hallux Valgus Market Size by Therapies in Spain<\/p>\n

15.7. United Kingdom Market Size<\/p>\n

15.7.1. Hallux Valgus Total Market Size in the United Kingdom<\/p>\n

15.7.2. Hallux Valgus Market Size by Therapies in the United Kingdom<\/p>\n

15.8. Japan Market Outlook<\/p>\n

15.8.1. Japan Market Size<\/p>\n

15.8.2. Hallux Valgus Total Market Size in Japan<\/p>\n

15.8.3. Hallux Valgus Market Size by Therapies in Japan<\/p>\n

16. Access and Reimbursement Overview of Hallux Valgus<\/strong><\/p>\n

17. KOL Views<\/strong><\/p>\n

18. Market Drivers<\/strong><\/p>\n

19. Market Barriers<\/strong><\/p>\n

20. Appendix<\/strong><\/p>\n

20.1. Bibliography<\/p>\n

20.2. Report Methodology<\/p>\n

21. DelveInsight Capabilities<\/strong><\/p>\n

22. Disclaimer<\/strong><\/p>\n

23. About DelveInsight<\/a>.<\/strong><\/p>\n

Why should you buy this report?<\/strong><\/p>\n

 <\/p>\n